BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hu X, Ding L, Cao S, Cheng L, Wang K, Guang C, Li W, Koike K, Qiu F. Pharmacokinetics, Tissue Distribution and Excretion of Paeonol and Its Major Metabolites in Rats Provide a Further Insight Into Paeonol Effectiveness. Front Pharmacol 2020;11:190. [PMID: 32180731 DOI: 10.3389/fphar.2020.00190] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Hua F, Shi L, Zhou P. Phenols and terpenoids: natural products as inhibitors of NLRP3 inflammasome in cardiovascular diseases. Inflammopharmacology 2022. [PMID: 35039992 DOI: 10.1007/s10787-021-00918-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Wang X, Su P, Hao Q, Zhang X, Xia L, Zhang Y. A Chinese classical prescription Guizhi-Fuling Wan in treatment of ovarian cancer: An overview. Biomedicine & Pharmacotherapy 2022;153:113401. [DOI: 10.1016/j.biopha.2022.113401] [Reference Citation Analysis]
3 Qian W, Li X, Liu Q, Lu J, Wang T, Zhang Q. Antifungal and Antibiofilm Efficacy of Paeonol Treatment Against Biofilms Comprising Candida albicans and/or Cryptococcus neoformans. Front Cell Infect Microbiol 2022;12:884793. [DOI: 10.3389/fcimb.2022.884793] [Reference Citation Analysis]
4 Wu M, Yu Z, Li X, Zhang X, Wang S, Yang S, Hu L, Liu L. Paeonol for the Treatment of Atherosclerotic Cardiovascular Disease: A Pharmacological and Mechanistic Overview. Front Cardiovasc Med 2021;8:690116. [PMID: 34368250 DOI: 10.3389/fcvm.2021.690116] [Reference Citation Analysis]